Sectors

The short bowel syndrome therapy developer has added $110m to the $35m with which it emerged from stealth in January.

TD Ameritrade and QBE-backed automation software producer Hyperscience has now raised in excess of $190m in total, Tiger Global Management leading its latest round.

Taiho Ventures and SR One co-led a series A round that will fund the early clinical progress of Dren's cancer and protein-depletion drug candidates.

Esenagro contributed to a round that lifted the vegan mince and meat producer's overall funding to nearly $80m in the past year.

Evotec and Boehringer Ingelheim Venture Fund returned in a $25.9m round for the autoimmune disease drug developer having first invested three years ago.

Chubu Electric Power, Daikin, Mitsubishi UFJ Capital, Mizuho Capital and SMBC Venture Capital were among the backers that helped Japan Data Science Consortium complete a $27.5m round.

Topas Therapeutics, which is exploiting University of Hamburg research, has pocketed $26m in its series B round.

The round was led by $8m from Leaps by Bayer and increased the microbiome skin treatment developer's total funding to $34m.

Nelson Education participated in a $15.2m round for Knowledgehook, which is mulling the expansion of its maths learning assessement platform to other subjects.

Main Sequence Ventures, which co-founded the meat-free burger producer last year, has returned for a $55m series B round.

Media group Emtek has sold its shares in PropertyGuru roughly a year after the real estate technology provider pulled back from plans to go public.